Cargando…
Interleukin-1: an important target for perinatal neuroprotection?
Perinatal inflammation is a significant risk factor for lifelong neurodevelopmental impairments such as cerebral palsy. Extensive clinical and preclinical evidence links the severity and pattern of perinatal inflammation to impaired maturation of white and grey matters and reduced brain growth. Mult...
Autores principales: | Kelly, Sharmony B., Green, Elys, Hunt, Rod W., Nold-Petry, Claudia A., Gunn, Alistair J., Nold, Marcel F., Galinsky, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241389/ https://www.ncbi.nlm.nih.gov/pubmed/35799507 http://dx.doi.org/10.4103/1673-5374.341044 |
Ejemplares similares
-
A systematic review of immune-based interventions for perinatal neuroprotection: closing the gap between animal studies and human trials
por: Kelly, Sharmony B., et al.
Publicado: (2023) -
Anakinra Pilot – a clinical trial to demonstrate safety, feasibility and pharmacokinetics of interleukin 1 receptor antagonist in preterm infants
por: Green, Elys A., et al.
Publicado: (2022) -
The Role of the Interleukin-1 Family in Complications of Prematurity
por: Green, Elys A., et al.
Publicado: (2023) -
Interleukin-1 blockade attenuates white matter inflammation and oligodendrocyte loss after progressive systemic lipopolysaccharide exposure in near-term fetal sheep
por: Kelly, Sharmony B., et al.
Publicado: (2021) -
The role of interleukin-1 in perinatal inflammation and its impact on transitional circulation
por: Owen, Josephine C., et al.
Publicado: (2023)